KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueDepreciation & Amortization (IS)EBIATGross ProfitLeasesLoans and Notes ReceivablesLong-Term Debt IssuancesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherNon-Current ReceivablesOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetReceivables - OtherReceivables RefundsShares OutstandingShares Outstanding
Ratios

Astrana Health (ASTH) Receivables Refunds (2021 - 2025)

Astrana Health (ASTH) has disclosed Receivables Refunds for 5 consecutive years, with $1.8 million as the latest value for Q4 2025.

  • Quarterly Receivables Refunds fell 90.69% to $1.8 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $1.8 million through Dec 2025, down 90.69% year-over-year, with the annual reading at $1.8 million for FY2025, 90.69% down from the prior year.
  • Receivables Refunds hit $1.8 million in Q4 2025 for Astrana Health, down from $7.9 million in the prior quarter.
  • In the past five years, Receivables Refunds ranged from a high of $22.0 million in Q2 2024 to a low of $1.4 million in Q2 2021.
  • Historically, Receivables Refunds has averaged $11.4 million across 5 years, with a median of $12.2 million in 2022.
  • Biggest five-year swings in Receivables Refunds: soared 786.33% in 2022 and later tumbled 90.69% in 2025.
  • Year by year, Receivables Refunds stood at $5.7 million in 2021, then soared by 115.29% to $12.2 million in 2022, then fell by 12.82% to $10.7 million in 2023, then skyrocketed by 81.25% to $19.3 million in 2024, then crashed by 90.69% to $1.8 million in 2025.
  • Business Quant data shows Receivables Refunds for ASTH at $1.8 million in Q4 2025, $7.9 million in Q2 2025, and $15.8 million in Q1 2025.